Adebrelimab

Warnings and Precautions

Immune-related side effects: by switching the immune system back on, this kind of medicine can also turn it against healthy organs. Such reactions may start during treatment or months after the last dose, and a small number in the trials were serious or fatal. Most improve once treatment is paused and steroids are given, which is why early reporting matters.

• Lungs: pneumonitis was seen in 4.3% of the 373 patients in the safety data. Tell your doctor about a new cough, breathlessness or chest pain.
• Liver: raised liver enzymes linked to the immune system occurred in 5.9%. Liver blood tests are done regularly; yellowing of the eyes or skin and dark urine need urgent attention.
• Thyroid and other glands: an underactive thyroid affected 8.0% and an overactive one 4.3%. Pituitary problems and high blood sugar were rare. Thyroid levels are checked during treatment.
• Bowel, skin, kidneys and heart: colitis or diarrhoea (1.9%), skin reactions (4.8%), low platelets (1.6%), kidney effects (0.5%) and myocarditis (0.3%) were also reported.
• Infusion reactions: 2.7% had chills, fever, chest tightness, rash or a drop in blood pressure during the drip, so it is always given under observation.
• Pregnancy and breastfeeding: it may harm an unborn baby. Use effective contraception during treatment and for 2 months after the last dose, and do not breastfeed during that time.
• Do not use if you have had an allergic reaction to adebrelimab or any of its ingredients.

Common side effects: alongside chemotherapy, the most frequent were hair loss (44.3%), nausea (40.0%), loss of appetite (29.6%), vomiting (26.1%), tiredness (18.3%), constipation (17.4%) and an underactive thyroid (12.2%). Low blood counts were very common, as they are with the chemotherapy itself. Only 1.7% of patients had to stop the antibody for good because of side effects.

How to Access Adebrelimab in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Adebrelimab to India?

The injection can be imported only in the patient's name, by the patient or a government hospital, in line with India's import regulations for unapproved medicines. You will need:

• A valid prescription from a qualified medical oncologist
• Diagnostic reports, such as the biopsy or cytology report confirming small cell lung cancer and recent staging scans
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

Once we have received and checked a valid prescription and, where needed, an import permit.

Is Adebrelimab available in India?

Not over the counter. It is approved only in China. It has no CDSCO approval and is not sold in Indian pharmacies, and the US FDA and European Medicines Agency have not approved it either.

Patients can still get it legally through the Named Patient Program (NPP). Under this route, a medicine that is not registered in India is imported for one specific patient, on that patient's prescription.

It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients, doctors, and hospitals under applicable legal provisions. The vials must stay between 2°C and 8°C, away from light, and must never freeze, so they travel under temperature-controlled shipping from pickup to hospital. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability Across Major Cities in India

Patients across India can access this medicine through regulated import pathways, with delivery arranged to the treating hospital on a valid oncologist's prescription.

Mumbai

One of the country's busiest centres for lung cancer care. Vials are delivered straight to the treating hospital's pharmacy against the named-patient papers.

Delhi

Cancer hospitals here receive patients from across North India. Being close to our New Delhi dispatch point keeps the cold-chain journey short.

Bangalore

Oncologists at the city's multispecialty and cancer hospitals can request the medicine for a specific patient, with the quote shared before anything is ordered.

Chennai

A long-standing referral hub for South India, used to handling refrigerated imported biologics.

Hyderabad

Delivery is planned around the patient's 3-weekly infusion date, so the vials arrive on time for each cycle.

Kolkata

For Kolkata and the eastern states, shipments are routed so the vials stay within 2°C to 8°C all the way.

Pune

Patients here can use the same documented import route, with updates at each stage of the shipment.

Ahmedabad

The treating oncologist can share the prescription and reports with us to start the import in the patient's name.

Kochi

Patients across Kerala can have the medicine delivered to their hospital in Kochi or nearby cities.

Chandigarh

Serves patients from Punjab, Haryana and Himachal Pradesh, with delivery to the hospital where treatment is given.

Jaipur

Patients in Rajasthan can start treatment without travelling abroad, as long as the import is in their name.

Lucknow

We coordinate delivery to both public and private cancer hospitals in Lucknow and across Uttar Pradesh.

Bhubaneswar

Odisha's growing cancer care centres can receive the medicine for named patients.

Guwahati

As the referral hub for the North-East, Guwahati hospitals can receive cold-chain deliveries for patients from the whole region.

Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.